Latest news
Zevra Therapeutics price target lowered to $24 from $27 at BTIG - TipRanksTipRanks · Fri, 07 Aug 2026 16:45:41 GMTsymbol__ Stock Quote Price and Forecast - CNNCNN · Fri, 07 Aug 2026 11:33:13 GMTZevra Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 08:04:07 GMTZevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 00:35:00 GMTZevra Reports Q2 2026: $39.7M Revenue, $8.8M Net Income, $260.2M Cash - TradingViewTradingView · Wed, 05 Aug 2026 20:47:58 GMTZevra Therapeutics to present at Canaccord Genuity Annual Growth Conference - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMTZevra Therapeutics Publishes Four-Year Real-World Data from U.S. Early Access Program Evaluating Miplyffa (Arimoclomol) in Niemann-Pick Disease Type C - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 16:20:59 GMTZevra Therapeutics Announces Publication of 4-Year Real-World Data on MIPLYFFA in Niemann-Pick Disease Type C - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:42:00 GMT